Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ERBB2 Altered Breast Cancer”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableLooking for participantsNCT06127979
What this trial is testing

Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01745965
What this trial is testing

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.

Who this might be right for
Breast Cancer
West German Study Group 380
Large-scale testing (Phase 3)Active Not RecruitingNCT05889390
What this trial is testing

Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer

Who this might be right for
HER2-negative Breast Cancer
Semmelweis University 71
Early research (Phase 1)Study completedNCT00485277
What this trial is testing

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Bavarian Nordic 9
Not applicableNot Yet RecruitingNCT07406594
What this trial is testing

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

Who this might be right for
Breast CancerHER-2 Positive Breast Cancer
University of Vermont Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01142778
What this trial is testing

Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 152
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493
What this trial is testing

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
West German Study Group 1,684
Early research (Phase 1)Study completedNCT01152398
What this trial is testing

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy

Who this might be right for
Breast Cancer
Bavarian Nordic 15
Not applicableStudy completedNCT03123263
What this trial is testing

Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer

Who this might be right for
Breast Cancer
Texas Tech University Health Sciences Center, El Paso 60
Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT01658033
What this trial is testing

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

Who this might be right for
Metastatic Breast Cancer
Fudan University 72
Testing effectiveness (Phase 2)WithdrawnNCT02547961
What this trial is testing

Chimeric Antigen Receptor-Modified T Cells for Breast Cancer

Who this might be right for
Breast Cancer
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Looking for participantsNCT07361562
What this trial is testing

A Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene Amplification+3 more
Cogent Biosciences, Inc. 100
Not applicableEnded earlyNCT02963363
What this trial is testing

Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Who this might be right for
HER2 Positive Breast Cancer
Centre Jean Perrin 36
Testing effectiveness (Phase 2)Looking for participantsNCT05770531
What this trial is testing

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Who this might be right for
Metastatic HER2-Negative Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma
Vanderbilt-Ingram Cancer Center 160
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 383
Testing effectiveness (Phase 2)Looking for participantsNCT07616427
What this trial is testing

Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer

Who this might be right for
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 100
Early research (Phase 1)Looking for participantsNCT04997993
What this trial is testing

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

Who this might be right for
PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Deborah Doroshow 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05810870
What this trial is testing

PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer
MedSIR 14
Testing effectiveness (Phase 2)Study completedNCT00524277
What this trial is testing

Vaccine Therapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
San Antonio Military Medical Center 456
Load More Results